Ewing sarcoma/peripheral primitive neuroectodermal tumor (EWS/pPNET) and other tumors with EWS gene rearrangements encompass a malignant and intermediate neoplasm with a broad anatomic distribution and a wide age range but a predilection for soft tissue in children, adolescents, and young adults. The overlapping histologic, immunohistochemical and cytogenetic and molecular genetic features create diagnostic challenges despite significant clinical and prognostic differences. Ewing sarcoma is the 3rd most common sarcoma in children and adolescents, and desmoplastic small round cell tumor is a rare neoplasm that occurs more often in older children, adolescents, and young adults. Pathologic examination is complemented by immunohistochemistry, cytogenetics, and molecular genetics. This article reviews the clinicopathologic features of EWS/pPNET and desmoplastic small round cell tumor in the spectrum of tumors with EWS gene rearrangements. Other tumors with different histopathologic features and an EWS gene rearrangement are discussed elsewhere in this volume.
Ewing sarcoma/peripheral n class="Disease">primitive neuroectodermal tumor (EWS/pPNET) and other tumors with EWS gene rearrangements encompass a malignant and intermediate neoplasm with a broad anatomic distribution and a wide age range but a predilection for soft tissue in children, adolescents, and young adults. The overlapping histologic, immunohistochemical and cytogenetic and molecular genetic features create diagnostic challenges despite significant clinical and prognostic differences. Ewing sarcoma is the 3rd most common sarcoma in children and adolescents, and desmoplastic small round cell tumor is a rare neoplasm that occurs more often in older children, adolescents, and young adults. Pathologic examination is complemented by immunohistochemistry, cytogenetics, and molecular genetics. This article reviews the clinicopathologic features of EWS/pPNET and desmoplastic small round cell tumor in the spectrum of tumors with EWS gene rearrangements. Other tumors with different histopathologic features and an EWS gene rearrangement are discussed elsewhere in this volume.
Authors: Chi L Braunreiter; Jeffrey D Hancock; Cheryl M Coffin; Kenneth M Boucher; Stephen L Lessnick Journal: Cell Cycle Date: 2006-12-01 Impact factor: 4.534
Authors: R B Raney; L Asmar; W A Newton; C Bagwell; J C Breneman; W Crist; E A Gehan; B Webber; M Wharam; E S Wiener; J R Anderson; H M Maurer Journal: J Clin Oncol Date: 1997-02 Impact factor: 44.544
Authors: A Zoubek; B Dockhorn-Dworniczak; O Delattre; H Christiansen; F Niggli; I Gatterer-Menz; T L Smith; H Jürgens; H Gadner; H Kovar Journal: J Clin Oncol Date: 1996-04 Impact factor: 44.544
Authors: Suzanne George; Priscilla Merriam; Robert G Maki; Annick D Van den Abbeele; Jeffrey T Yap; Timothy Akhurst; David C Harmon; Gauri Bhuchar; Margaret M O'Mara; David R D'Adamo; Jeffrey Morgan; Gary K Schwartz; Andrew J Wagner; James E Butrynski; George D Demetri; Mary L Keohan Journal: J Clin Oncol Date: 2009-05-18 Impact factor: 44.544
Authors: E E King; Y Qin; R A Toledo; A Luo; E Ball; F R Faucz; K A Janeway; C A Stratakis; G E Tomlinson; P L M Dahia Journal: Endocr Relat Cancer Date: 2015-03-13 Impact factor: 5.678